- Plaintiff
- Accutane Plaintiffs
- Plaintiff
- McCarrell, Andrew
- Represented By:
- Smith, Paul (Paul L. Smith and Associates)
This is the October, 2008, Accutane trial.
Also available, the original trial McCarrell v. Hoffman LaRoche, and the July 2009 re-trial of McCarrell v. Hoffman LaRoche.
This class action against the acne drug Accutane, manufactured by Hoffman-La Roche, Inc., involves plaintiffs who have suffered severe inflammatory bowel disease after taking the drug.
Representative for the class, Andrew McCarrell, has undergone multiple surgeries after taking the drug in 1995, including having his colon removed.
At the trial level, in May 2007, a jury held that Accutane had caused McCarrell�s inflammatory bowl disease and the proceeding colon removal. Specifically, the jury found that Hoffman- La Roche failed to adequately warn a patient of the bowel disease risks associated with its potent acne medicine Accutane, and they awarded him $2.5 million in damages and an additional $119,000 to cover medical expenses.
On May 12, 2009 New Jersey's Court of Appeals vacated the trial court's verdict. The appellate court held harmful error occurred when the trial court did not allow La Roche to present evidence of how many people take Accutane.
Kelly Mace:
Injuries/Future Medical Expenses: 128,000
Pain and Suffering: 1.5 mil
Lance Sager:
Injuries/Future Medical Expenses: 125,000
Pain and Suffering: 2.5 mil
Jordan Speisman:
Injuries/Future Medical Expenses: 142,500
Pain and Suffering: 8.5 mil
Description | Attorney | Witness | Presence | |||
---|---|---|---|---|---|---|
00:00:00 | General Case Activities | |||||
00:05:24 | Opening Statement | Hook, Michael | In Person | |||
01:15:27 | End of Session |
Copyright 2024 Courtroom Connect.